For weight management , NICE technology appraisals TA875 (semaglutide/Wegovy) and TA664 (liraglutide/Saxenda) recommend these treatments for adults with: A BMI of 35 kg/m or more with at least one weight-related comorbidity, or A BMI of 3034.9 kg/m with at least one weight-related comorbidity Lower BMI thresholds (reduced by 2.5 kg/m) apply for people from Black, Asian, and other minority ethnic family backgrounds
Se recomienda un control oftalmolgico regular, especialmente durante el inicio del tratamiento
Then mice were randomised into three groups: (1) a group kept on HFD and treated with semaglutide plus BI8271 (HFD-SY, n =12) as described above
Of the remaining 1503 records screened for titles and abstracts, 1482 were excluded
To obtain a prescription, you still need to talk to a doctor, who is tasked with assessing your medical history and needs
Risk-benefit discussion of medication options